Social Capital Suvretta Holdings Corp. IV, trading under the ticker DNAD on Nasdaq, is a blank-check company that completed its initial public offering in January 2021. It was the fourth in a quartet of healthcare-focused SPACs launched simultaneously by sponsor Social Capital Suvretta Holdings Management LLC, a joint venture between Chamath Palihapitiya's Social Capital and Suvretta Capital Management, a dedicated healthcare investment firm led by Aaron Cohen. All four vehicles — DNAA through DNAD — were structured to pursue targets in the clinical-stage biopharmaceutical and life-sciences sector. The July 2021 8-K filing reflects a disclosure event during the company's search period. For complete filings, merger activity, and sponsor analytics on DNAD and the full Social Capital Suvretta series, sign up for full data access on SpacDesk.